Shimizu C - Search Results

1

Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study.

Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M. Im SA, et al. Among authors: shimizu c. J Glob Oncol. 2019 May;5:1-19. doi: 10.1200/JGO.18.00173. J Glob Oncol. 2019. PMID: 31125276 Free PMC article. Clinical Trial.

2

[Genetic testing for effective Herceptin therapy].

Watanabe T, Katsumata N, Ando M, Mukai H, Shimizu C, Kitagawa R, Saijo NG. Watanabe T, et al. Among authors: shimizu c. Nihon Rinsho. 2002 Mar;60(3):603-11. Nihon Rinsho. 2002. PMID: 11904980 Review. Japanese.

3

Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.

Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA, Toi M. Saji S, et al. Among authors: shimizu c. Cancer Res. 2002 Sep 1;62(17):4849-53. Cancer Res. 2002. PMID: 12208729

4

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

Mizuno T, Katsumata N, Mukai H, Shimizu C, Ando M, Watanabe T. Mizuno T, et al. Among authors: shimizu c. Support Care Cancer. 2007 Mar;15(3):287-91. doi: 10.1007/s00520-006-0126-6. Epub 2006 Aug 29. Support Care Cancer. 2007. PMID: 16941132

5

Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer.

Shimizu C, Ando M, Kouno T, Katsumata N, Fujiwara Y. Shimizu C, et al. Jpn J Clin Oncol. 2007 Jan;37(1):1-8. doi: 10.1093/jjco/hyl122. Epub 2007 Jan 3. Jpn J Clin Oncol. 2007. PMID: 17202251 Review.

6

Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed.

Mukai H, Watanabe T, Ando M, Shimizu C, Katsumata N. Mukai H, et al. Among authors: shimizu c. Breast Cancer Res Treat. 2009 Jan;113(1):123-8. doi: 10.1007/s10549-007-9889-9. Epub 2008 Jan 10. Breast Cancer Res Treat. 2009. PMID: 18193480

7

Clinical efficacy of S-1 in pretreated metastatic breast cancer patients.

Shien T, Shimizu C, Akashi-Tanaka S, Yonemori K, Kohno T, Hojo T, Ando M, Katsumata N, Kinoshita T, Fujiwara Y. Shien T, et al. Among authors: shimizu c. Jpn J Clin Oncol. 2008 Mar;38(3):172-5. doi: 10.1093/jjco/hyn001. Epub 2008 Feb 22. Jpn J Clin Oncol. 2008. PMID: 18296424

8

Ono M, Watanabe T, Shimizu C, Hiramoto N, Goto Y, Yonemori K, Kouno T, Ando M, Tamura K, Katsumata N, Fujiwara Y. Ono M, et al. Among authors: shimizu c. Jpn J Clin Oncol. 2008 Aug;38(8):567-70. doi: 10.1093/jjco/hyn057. Epub 2008 Jul 10. Jpn J Clin Oncol. 2008. PMID: 18617535

9

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.

Nishio S, Katsumata N, Matsumoto K, Tanabe H, Yonemori K, Kouno T, Shimizu C, Ando M, Kamura T, Kasamatsu T, Fujiwara Y. Nishio S, et al. Among authors: shimizu c. J Cancer Res Clin Oncol. 2009 Apr;135(4):551-7. doi: 10.1007/s00432-008-0488-x. Epub 2008 Oct 1. J Cancer Res Clin Oncol. 2009. PMID: 18830625

10

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer.

Ono M, Ando M, Yunokawa M, Nakano E, Yonemori K, Matsumoto K, Kouno T, Shimizu C, Tamura K, Katsumata N, Fujiwara Y. Ono M, et al. Among authors: shimizu c. Int J Clin Oncol. 2009 Feb;14(1):48-52. doi: 10.1007/s10147-008-0797-8. Epub 2009 Feb 20. Int J Clin Oncol. 2009. PMID: 19225924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

698 results

Search Page